Home/ Stocks/ CERT

Certara, Inc. Common Stock

CERT XNAS

$8.20 +0.07 (+0.86%) ▲ 15-min delayed

Open

$8.13

High

$8.29

Low

$8.06

Volume

2.38M

Market Cap

$1.24B

About Certara, Inc. Common Stock

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Sector: SERVICES-PREPACKAGED SOFTWARE Employees: 1.6K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$93.27M	$-55,270,000	$-0.36
Q1 2026	$106.92M	$-8,763,000	$-0.06
FY 2025	$418.84M	$-1,595,000	$-0.01
Q3 2025	$104.62M	$1.52M	$0.01

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for CERT yet. Check out our latest market news or earnings calendar.

Get CERT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Certara, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.